Biopharmaceutical Manufacturing, Upstream, Downstream processing news

Headlines

J&J chooses lead coronavirus candidate, sets up manufacturing for 1 billion doses

The company provides update on its coronavirus plans, which includes $1bn in funding to research and expected Phase I trial commencement date.

Novartis’ gene therapy takes additional step towards EU approval

Zolgensma has received a recommendation for approval despite running into problems recently, including manufacturing questions and data integrity issues.

Takeda taps Evox for exosome therapeutics

The partners will focus on developing five potential exosome treatment for rare diseases.

Gates Foundation in ‘unprecedented’ coronavirus partnership with industry

‘Collective action is critical,’ says Novartis CEO on industry partnership with Gates Foundation to accelerate treatments for COVID-19.

Astellas and CytomX team up to target solid tumors with T-cells

The two partners will work to develop clinical candidates for the treatment of cancer.

Global Industry News

Hot Topics

Spotlight

BioStem adds R&D laboratory space to Florida site

Roche ups Actemra production anticipating increased demand

Thermo Fisher to invest $475m into biopharma in 2020

Lonza launches insect medium enabling increased AAV production

Insulin designated biologic in ‘landmark moment’

Products

Webinars

On-demand webinars

Marken Exploring the value of home visits in clinical trials, the benefits gained by both the patient and the sponsor

Featured Suppliers

All suppliers

Baxter BioPharma Solutions

Marken